Related Experiment Video
Updated: Aug 14, 2025
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
Recent Developments in the Study of the Microenvironment of Cancer and Drug Delivery
Benu Chaudhary1, Parveen Kumar2, Preeti Arya1
1Department of Pharmacology, Guru Gobind Singh College of Pharmacy, Yamunanagar, Haryana, India.
Abstract:
Cancer is characterized by disrupted molecular variables caused by cells that deviate from regular signal transduction. The uncontrolled segment of such cancerous cells annihilates most of the tissues that contact them. Gene therapy, immunotherapy, and nanotechnology advancements have resulted in novel strategies for anticancer drug delivery. Furthermore, diverse dispersion of nanoparticles in normal stroma cells adversely affects the healthy cells and disrupts the crosstalk of tumour stroma. It can contribute to cancer cell progression inhibition and, conversely, to acquired resistance, enabling cancer cell metastasis and proliferation. The tumour's microenvironment is critical in controlling the dispersion and physiological activities of nano-chemotherapeutics which is one of the targeted drug therapy. As it is one of the methods of treating cancer that involves the use of medications or other substances to specifically target and kill off certain subsets of malignant cells. A targeted therapy may be administered alone or in addition to more conventional methods of care like surgery, chemotherapy, or radiation treatment. The tumour microenvironment, stromatogenesis, barriers and advancement in the drug delivery system across tumour tissue are summarised in this review.
Insights
This review explores how the tumor microenvironment influences nanoparticle-based cancer drug delivery. Understanding these interactions is key for developing effective targeted therapies and overcoming drug resistance.
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Cancer involves disrupted molecular signaling and uncontrolled cell growth, necessitating advanced treatment strategies.
- Nanoparticle drug delivery offers novel anticancer approaches but faces challenges with dispersion in healthy tissues and tumor microenvironment interactions.
- The tumor microenvironment critically impacts the efficacy and behavior of nano-chemotherapeutics.
Purpose of the Study:
- To review the role of the tumor microenvironment in nano-chemotherapeutic dispersion and activity.
- To summarize advancements in drug delivery systems for targeting tumor tissues.
- To discuss the implications of nanoparticle interactions within the tumor stroma.
Main Methods:
- Literature review focusing on cancer biology, nanotechnology, and targeted drug delivery.
- Analysis of studies investigating nanoparticle behavior within the tumor microenvironment.
- Synthesis of information on stromatogenesis and barriers to drug delivery.
Main Results:
- Nanoparticle dispersion affects both healthy stroma cells and tumor progression, potentially inhibiting growth or promoting resistance.
- The tumor microenvironment dictates the physiological activities and distribution of nano-chemotherapeutics.
- Targeted drug therapy, including nanoparticle-based approaches, is a key strategy in cancer treatment.
Conclusions:
- Effective cancer treatment relies on understanding and manipulating the tumor microenvironment for optimal drug delivery.
- Advancements in drug delivery systems are crucial for enhancing the efficacy of targeted therapies.
- Further research into tumor microenvironment dynamics can lead to improved strategies against cancer metastasis and proliferation.
More Related Videos
08:52Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
